Daily non-political popular news in brief.

Brief, High-dose Steroid Treatment Offers Extended Relief To Giant Cell Arteritis Patients

A new study offers both hope and a practical treatment option for patients with giant cell arteritis (GCA). Researchers from Emory University and the Mayo Clinic have found that by treating newly diagnosed GCA patients with just three days of a high-dose intravenous steroid, patients relapsed less in the following year and were able to significantly taper off usage of an oral steroid.

Read more »

Keywords: brief, high-dose, steroid, treatment, offers, extended, relief, giant, cell, arteritis, patients, high, dose, offer, arteriti, patient

« Previous | Next »

Similar news on "Brief, High-dose Steroid Treatment Offers Extended Relief To Giant Cell Arteritis Patients":

1. Tip sheet for Annals of Internal Medicine -- May 1, 2007, issue
   04-30-2007 · EurekAlert!
   Two studies in the May 1, 2007, Annals of Internal Medicine find that infliximab, a widely used anti-tumor necrosis drug, has no benefit in patients receiving standard corticosteroid treatment for giant-cell arteritis or polymyalgia rheumatica.
   Similar news · Read more »
   
2. Advanced therapy offers cure for relapsed cancer patient
   07-25-2007 · EurekAlert!
   Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine study by Lawrence Einhorn, M.D.; Stephen Williams, M.D.; Rafat Abonour, M.D., and colleagues published in the July 26 issue of the New England Journal of Medicine. Although the number of relapsed testicular cancer patients in the US is small, the IU Simon Cancer Center treats a majority of them.
   Similar news · Read more »
   
3. Deep brain stimulation offers new hope for dystonia treatment
   11-21-2006 · EurekAlert!
   Dystonia, a group of diseases that cause a patient's muscles to involuntary contract with movement, has had a relatively limited and ineffective number of treatments in the past. New research shows that a recently developed surgical treatment, deep brain stimulation (an off switch for the brain), has provided dramatic benefits in some patients.
   Similar news · Read more »
   
4. Developments in tissue engineering offer new sources for stem cell treatments
   05-21-2007 · EurekAlert!
   Tissue engineering and regenerative medicine offer future patients greater options for treatment and cure of a wide array of urologic conditions, and controversies surrounding the sources of stem cells as well as their use have fueled increased research. A special session for media highlighting this research was held on May 21 at 9:00 a.m. PDT.
   Similar news · Read more »
   
5. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
6. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
7. Personalized diets may offer relief to advanced cancer patients
   03-09-2007 · EurekAlert!
   Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
   Similar news · Read more »
   
8. Stem cell procedure successfully treats amyloidosis patients
   07-03-2007 · EurekAlert!
   Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that tandem cycles of high-dose chemotherapy and blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment with this method.
   Similar news · Read more »
   
9. New cancer treatment adds to survival rates in lung cancer patients
   06-28-2007 · EurekAlert!
   Patients with inoperable non-small cell lung cancer who receive an initial high dose of chemotherapy before their treatment begins can expect an increase in overall survival, according to a study in the July 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of ASTRO.
   Similar news · Read more »
   
10. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
    08-07-2007 · EurekAlert!
    Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain Amyloidosis.
    Similar news · Read more »